Estée Lauder Companies (EL) is a global leader in prestige beauty, offering luxury skincare, makeup, fragrance, and haircare through 20-plus iconic brands like Estée Lauder, Clinique, La Mer, MAC, and more. The company markets its products via department stores, specialty retailers, travel retail, e-commerce, and salons, focusing on high-end products with science-backed innovation. Known for anti-aging serums, clean beauty lines, and personalized regimens, it blends heritage craftsmanship with cutting-edge research and development.
Founded in 1946 by Estée and Joseph Lauder, the company is headquartered in New York, New York and operates in more than 150 countries across North America, South America, the Middle East, Europe, and Asia-Pacific.
EL stock has been volatile lately, tumbling 12% over the past five days and 10% in the last month. Shares have rebounded by 14% over the past three months and 13% in six months, but the stock is still down by 2% year-to-date (YTD). Over the past 52 weeks, shares of EL stock are up by 49%, trading 15% lower than the high of $121.64.
Against the S&P 500 Consumer Staples Index ($SRCS), Estée Lauder has lagged short-term, where its negative returns have underperformed the index’s 1.3% five-day gain and 10% one-month rise. Over the past 52 weeks, however, Estée Lauder comfortably beats the index’s 9% returns, fueled by recovery from lows.
Estée Lauder reported solid second-quarter fiscal 2026 results, posted on Feb. 05, where revenue rose approximately 6% year-over-year (YOY) to $4.23 billion, matching Wall Street forecasts exactly. Net income reached $162 million, or $0.44 per share, while adjusted EPS was $0.89, beating analyst estimates of $0.84 by 6%.
Gross margin improved slightly to 76.5% from 76.1%. Adjusted operating income rose to $608 million (14.4% margin, up 290 basis points), reflecting cost controls. First-half operating cash flow surged to $785 million from $387 million, boosted by lower capex. Organic sales grew 4%, a positive turnaround after declines.
Estée Lauder raised its full-year fiscal 2026 outlook following a strong first-half performance, although it remains cautious amid macroeconomic headwinds and business challenges. Net sales growth is now projected at 3% to 5% YOY, tightened from the prior 2% to 5% range. Adjusted organic net sales are expected to rise 1% to 3%, up from 0% to 3%. Adjusted EPS guidance improved to between $2.05 and $2.25, reflecting 36% to 49% growth.
